Vunakizumab Uses, Dosage, Side Effects and more
Vunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis).
Trade Name | Vunakizumab |
Generic | Vunakizumab |
Vunakizumab Other Names | Vunakizumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |